Iwasaka-Yagi, C <br/><br/>
TGF-beta attenuates the transactivation activity of Ets-1 despite its induction via the inhibition of DNA binding.  [electronic resource] 

 -  The Tohoku journal of experimental medicine  Apr 2001 
 - 311-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0040-8727 
<br/><br/><label>Standard No.: </label>10.1620/tjem.193.311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Line, Transformed<br/>Culture Media, Serum-Free--pharmacology<br/>Cycloheximide--pharmacology<br/>DNA--metabolism<br/>Depression, Chemical<br/>Endothelium, Vascular--cytology<br/>Fibroblast Growth Factor 2--metabolism<br/>Gene Expression Regulation--drug effects<br/>Genes, Reporter<br/>Humans<br/>Luciferases--biosynthesis<br/>Matrix Metalloproteinase 1--genetics<br/>Promoter Regions, Genetic--drug effects<br/>Protein Binding--drug effects<br/>Protein Synthesis Inhibitors--pharmacology<br/>Proto-Oncogene Protein c-ets-1<br/>Proto-Oncogene Proteins--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-ets<br/>RNA, Messenger--biosynthesis<br/>Recombinant Fusion Proteins--biosynthesis<br/>Transcription Factors--antagonists & inhibitors<br/>Transcriptional Activation--drug effects<br/>Transfection<br/>Transforming Growth Factor beta--pharmacology